•
Dec 31, 2023

Ascendis Pharma Q4 2023 Earnings Report

Total Revenue
$148M
Previous year: $23.4M
+533.7%
EPS
-$1.66
Previous year: -$3.78
-56.1%
Gross Profit
$122M
Cash and Equivalents
$441M
Free Cash Flow
-$39.6M
Total Assets
$912M

Ascendis Pharma

Ascendis Pharma